StockTwits, founded in 2008 by Howard Lindzon and Soren Macbeth, is a leading social media platform designed specifically for investors and traders to share real-time market insights, ideas, and strategies. Headquartered in New York City, the company pioneered the use of "cashtags" (e.g., $AAPL) to organize financial discussions, initially integrating with Twitter before evolving into a standalone network.
The minutes also showed that labor market weakness remained among the top concerns of the central bank, which noted that though the unemployment rate remained low, the pace of employment increases had slowed.
Federal tax credit of $7,500 on the purchase of new EVs expired on Sept. 30, raising prices for end customers and creating concerns about EV demand in the fourth quarter.
The plaintiffs in the case are former CEO Parag Agrawal, former CFO Ned Segal, former chief legal officer Vijaya Gadde, and former general counsel Sean Edgett.
The companies have signed a non-binding Letter of Intent (LOI) outlining plans for REalloys to receive up to 15% of annual rare earth concentrate from Critical Metals’ Tanbreez Project in Southern Greenland.
In an interview with CNBC, Huang stated that the current AI investments are part of a multi-trillion-dollar business and that this is just the beginning.
YZi Labs said its $1 billion builder fund is focused on BNB projects working on trading, real-world assets (RWAs), artificial intelligence (AI), decentralized science (DeSci), decentralized finance (DeFi), payments, and wallets.
JPMorgan lifted its price target for Dell from $145 to $165 and maintained an ‘Overweight’ rating, citing that Dell’s performance metrics revealed during the event not only met but surpassed internal expectations.
The xAI deal reportedly envisions a $2 billion contribution by Nvidia, as the former plans to raise $7.5 billion in equity and $12.5 billion in debt financing.
The sweeping leadership changes mark another step in CEO Antonio Filosa’s effort to streamline operations and position Stellantis for its next phase of growth following a series of management shake-ups this year.
Investors turned upbeat ahead of Sarepta’s data presentations in Vienna, where the company is expected to share new Duchenne muscular dystrophy results and updates from its broader gene therapy pipeline.
